Association of free fatty acids with the insulin-resistant state but not with central obesity in individuals from Venezuela

Investigacion Clinica

Volumn 51, Issue 1, 2010, Pages 115-126

  Campos, Gilberto ^a   Fernández, Virginia ^a   Fernández, Erika ^a   Molero, Emperatriz ^a   Morales, Luz Marina ^a   Raleigh, Xiomara ^a   Connell, Lissette ^a   Ryder, Elena ^a  

^a UNIVERSIDAD DEL ZULIA   (Venezuela)

Author keywords

Free fatty acids; Insulin resistance; Obesity; Subcutaneous fat; Venezuelans

Indexed keywords

FATTY ACID; GLUCOSE; INSULIN;

ADULT; ANTHROPOMETRY; ARTICLE; BODY MASS; CARBOHYDRATE METABOLISM; CLINICAL ARTICLE; FATTY ACID BLOOD LEVEL; FEMALE; GLUCOSE TOLERANCE TEST; HUMAN; INSULIN RESISTANCE; LIPID METABOLISM; LIPOLYSIS; MALE; OBESITY; SKINFOLD; SUBCUTANEOUS FAT; VENEZUELA; WAIST CIRCUMFERENCE; ABDOMINAL OBESITY; BLOOD; METABOLISM; MIDDLE AGED; YOUNG ADULT;

ADULT; FATTY ACIDS; FEMALE; HUMANS; INSULIN RESISTANCE; MALE; MIDDLE AGED; OBESITY, ABDOMINAL; VENEZUELA; YOUNG ADULT;

EID: 77953274688     PISSN: 05355133     EISSN: 05355133     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Boden G. Free fatty acids-the link between obesity and insulin resistance. Endocr Pract 2001; 7: 44-51. (Pubitemid 32834246)
2. Mead JR, Irvine SA, Ramji DP. Lipoprotein lipase: structure, function, regulation, and role in disease. J Mol Med 2002; 80:753-769.
3. Ryder E, Gomez ME, Fernandez V, Campos G, Morales LM, Valbuena H, Raleigh X. Presence of impaired insulin secretion and insulin resistance in normoglycemic male subjects with family history of type 2 diabetes. Diabetes Res Clin Pract 2003; 60: 95-103. (Pubitemid 36434260)
4. Campos G, Ryder E, Diez-Ewald M, Rivero F, Fernandez V, Raleigh X. Prevalence of obesity and hyperinsulinemia in association with serum lipid and lipoprotein concentrations in healthy individuals from Maracaibo, Venezuela. Invest Clin 2003; 44:5-19. (Pubitemid 36433896)
5. Florez H, Silva E, Fernandez V, Ryder E, Sulbaran T, Campos G, Calmon G, Clavell E, Castillo-Florez S, Goldberg R. Prevalence and risk factors associated with the metabolic syndrome and dyslipidemia in White, Black, Amerindians and Mixed Hispanics in Zulia state, Venezuela. Diabetes Res Clin Pract 2005; 69:63-77. (Pubitemid 40813413)
6. Friedewald WT, Levy R, Frederickson DS. Estimation of serum low density lipoprotein without the use of a preparative ultracentrifuge. Clin Chem 1972; 18:499-502.
7. Matthews DR, Hosker JP, Rudenski AD, Neylor BA, Tracher DF, Turner RL. Homeostasis model assessment: insulin resistance and beta cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985; 28:412-419. (Pubitemid 15018832)
8. Boyle MJ. The experience of linking Victorian emergency medical trauma data. BMC Med Inform Decis Mak 2008; 8:52.
9. Yeni-Komshian H, Carantoni M, Abassi F, Reaven GM. Relationship between several surrogate estimates of insulin resistance and quantification of insulin-mediated glucose disposal in 490 healthy non diabetics volunteers. Diabetes Care 2000; 23: 171-175. (Pubitemid 30071019)
10. Boden G, Shulman GI. Free fatty acids in obesity and type 2 diabetes: defining their role in the development of insulin resistance and beta-cell dysfunction. Eur J Clin Invest 2002; 32(Suppl 3): 14-23. (Pubitemid 41704996)
11. Wilding JP. The importance of free fatty acids in the development of Type 2 diabetes. Diabet Med 2007; 24: 934-935.
12. Ye J. Role of insulin in the pathogenesis of free fatty acid-induced insulin resistance in skeletal muscle. Endocr Metab Immune Disord Drug Targets 2007; 7:65-74. (Pubitemid 46380417)
13. Richelsen B, Pedersen SB, Moller-Pedersen T, Bak JF. Regional differences in triglyceride breakdown in human adipose tissue: effect of catecholamines, insulin, and prostaglandin E2. Metabolism 1991; 40:990-996.
14. Bains RK, Wells SE, Flavell DM, Fairhall KM, Strom M, Le Tissier P, Robinson IC. Visceral obesity without insulin resistance in late-onset obesity rats. Endocrinology 2004; 145: 2666-2679. (Pubitemid 38686213)
15. Katterle Y, Keipert S, Hof J, Klaus S. Dissociation of obesity and insulin resistance in transgenic mice with skeletal muscle expression of uncoupling protein 1. Phsyiol Genomics 2008; 32:352-359. (Pubitemid 351328558)
16. Defay R, Jaussent I, Lacroux A, Fontbonne A. Relationships between glycaemic abnormalities, obesity and insulin resistance in nondiabetic Polynesians of New Caledonia. Int J Obes 2007; 31:109-113. (Pubitemid 46006023)
17. Cournil A, Defay R, Lacroux A, Barny S. Fontbonne A for the CALDIA Study Group. Paradoxical relationships between anthropometric variables and phenotypic expression of the metabolic syndrome in nondiabetic Polynesians of New Caledonia. Diabetes Care 2007; 30:1909-1911.
18. Lebovitz HE, Banerji MA. Visceral adiposity is causally related to insulin resistance. Diabetes Care 2005; 28:2322-2325. (Pubitemid 41242490)
19. Abate N, Garg A, Peshock RM, Stray-Gundersen J, Grundy SM. Relationship of generalized and regional adiposity to insulin sensitivity in men. J Clin Invest 1995; 96:88-98.
20. Goodpaster BH, Thaete FL, Simoneau J-A, Kelley DE. Subcutaneous abdominal fat and thigh muscle composition predict insulin sensitivity independently of visceral fat. Diabetes 1997; 46:1579-1585.
21. Kelley DE, Thaete FL, Troost F, Huwe T, Goodpaster BH. Subdivisions of subcutaneous abdominal adipose tissue and insulin resistance. Am J Physiol Endocrinol Metab 2000; 278:E941-E948.
22. Koutsari C, Jensen MD. Free fatty acid metabolism in human obesity. J Lipid Res 2006; 47:1643-1650.
23. Nielsen S, Guo Z, Johnson CM, Hensrud DD, Jensen MD. Splanchnic lypolysis in human obesity. J Clin Invest 2004; 113: 1582-1588.
24. Klein S. The case of visceral fat: argument for the defense (Editorial). J Clin Invest 2004; 113:1530-1531.
25. Gulli G, Ferranini E, Stern M, Haffner S, DeFronzo RA. The metabolic profile of NIDDM is fully established in glucose tolerant offspring of two Mexican American NIDDM parents. Diabetes 1992; 41:1575-1586.